… ProQR spins out Amylon Therapeutics as a privately-held company focused on … Key updates ProQR spins out CNS-focused company, Amylon Therapeutics, with seed funding from a group of … that the company has spun out Amylon Therapeutics (Amylon), a privately-held company focused on the development …
… 2018, with interim data also expected in 2018. Spin-out of Amylon Therapeutics as a privately-held company focused on … Axiomer ® . We are also thrilled with the spin out of Amylon as a privately-held company to a group of private and … investors, while maintaining our majority ownership in Amylon. This enables the program to attract external funding …
LEIDEN, the Netherlands, Jan. 08, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR), today announced that it has entered into a research collaboration agreement with Galapagos N.V. (Euronext & NASDAQ:GLPG).